ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2014

Abstract Number: 2640

Prevalence and Predictors of ECG Cardiovascular Abnormalities in Lupus Patients

Zahi Touma1, Paula Harvey2, Dafna D. Gladman3, Dominique Ibanez1, Arthy Sabapathy3 and Murray B. Urowitz3, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2Cardiology, Women's College Hospital, Toronto, ON, Canada, 3University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: cardiovascular disease and systemic lupus erythematosus (SLE)

Session Information

Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Epidemiology, Women's Health, Cardiovascular and CNS

Session Type: Abstract Submissions (ACR)

Background/Purpose:   Patients with lupus are at increased risk for cardiovascular disease. Previous studies on healthy adults showed that abnormalities detected on resting electrocardiography (ECG) are associated with an increased risk for subsequent cardiovascular (CV) events. These ECG-CV abnormalities are: ST-segment and/or T-wave abnormalities, left ventricular hypertrophy (LVH), left-axis deviation and bundle branch block (BBB).

We aimed to determine the prevalence of ECG-CV abnormalities in a cohort of lupus patients and to examine the factors associated with ECG-CV abnormalities.

Methods:   A standard digitally recorded 12-lead resting supine ECG was performed on consecutive patients attending the Lupus Clinic between October 2012-May 2014. Coded ECGs were reviewed and interpreted by a cardiologist using the Minnesota code classification system.

The frequency of the ECG-CV abnormalities was determined. In the univariate analysis normal ECG and ECG-CV abnormalities were compared (T-test and chi-squared test). Covariates with p<0.1 in addition to age, sex and ethnicity were evaluated with a stepwise logistic regression model to predict the ECG-CV abnormalities.

Results:   461 patients were studied. Of the 461 resting ECGs, 39.5% were abnormal: 7.6% axis deviation, 3.5% atrial enlargement, 11.3% arrhythmia and 6.7% pathological Q waves. ECG-CV abnormalities were present in 120 patients and included: ST-segment abnormalities and/or T-wave abnormalities  in 17.4%, LVH in 8.9%, left-axis deviation in 4.1% and BBB in 6.3%.

Of the 120 patients with ECG-CV abnormalities, 65.0% had 1 abnormality, 26.7% had 2, 6.7% had 3 and 1.7% had all 4 abnormalities.

In the univariate analysis, in the group of ECG-CV abnormalities, patients were older, had a longer lupus duration, higher damage index, higher cumulative dose of corticosteroids, history of previous CAD event, presence of Coombs’, La, LE cells, SCL70 and anti phospholipid lupus antibodies (table 1).

In the multivariate analysis, older age (OR =1.03; 95% CI: 1.01, 1.05; p=0.002), presence of damage (OR= 1.33; 95% CI: 1.17, 1.52; p<0.0001) and positive Coombs' (OR=2.37; 95% CI: 1.34, 4.21; p=0.003) were associated with ECG-CV abnormalities.

Conclusion:   Of 461 resting ECGs 39.5% were abnormal. 26% had ECG-CV abnormalities. Older age, damage and Coombs’ test were associated with ECG-CV abnormalities. These patients are at higher risk of developing CV events.

 

Table 1. Comparison of normal ECG and ECG-CV abnormalities

  Normal ECG (n=279) ECG-CV abnormalities  (n=120) p
Sex        Female 91.0% 88.3% 0.40
Race    Caucasian Black Asian Other   57.0% 15.8% 11.5% 15.8%   60.0% 23.3% 7.5% 9.2%     0.08
Age   @ SLE Dx                      at visit closest ECG 30.3 ± 11.5 45.9 ± 13.0 30.6 ± 11.2 52.3 ± 14.8 0.84 <0.0001
Disease Duration @ ECG 15.6 ± 10.2 21.7 ± 12.5 <0.0001
SLEDAI-2K First available in clinic                       at visit closest ECG 9.2 ± 8.1 3.7 ± 4.3 9.1 ± 7.5 3.5 ± 4.3 0.87 0.75
SDI > 0         at visit closest ECG 60.4% 80.3% 0.0001
SDI               at visit closest ECG 1.29 ± 1.53 2.82 ± 2.62 <0.0001
SDI (Excluding Cardio) at visit closest ECG 1.24 ± 1.48 2.46 ± 2.39 <0.0001
Steroids   at visit closest ECG               Cumulative Dose at visit closest ECG (gr) 87.5% 33.8 ± 34.9 91.7% 61.3 ± 55.6 0.22 <0.0001
CAD         First available in clinic                  at visit closest ECG 0% 4.3% 1.7% 17.5% 0.09 <0.0001
Coombs  First available in clinic                 at visit closest ECG 32.2% 63.8% 40.7% 80.5% 0.11 0.001
LA           First available in clinic                 at visit closest ECG 18.3% 33.6% 22.2% 47.5% 0.44 0.009
LE           First available in clinic                                         at visit closest ECG 37.2% 58.1% 47.8% 73.0% 0.06 0.006
SCL70    First available in clinic                at visit closest ECG 7.7% 19.7% 11.7% 35.8% 0.28 0.0006
APLA    First available in clinic               at visit closest ECG 26.3% 50.4% 27.4% 61.3% 0.82 0.045

Other studied variables: AMS 3 years prior ECG, antimalarials and immunosuppressants ever @ ECG, Jo1, RNP, Ro, ANCA, anti dsDNA and ANA (p>0.05).

 


Disclosure:

Z. Touma,
None;

P. Harvey,
None;

D. D. Gladman,
None;

D. Ibanez,
None;

A. Sabapathy,
None;

M. B. Urowitz,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-predictors-of-ecg-cardiovascular-abnormalities-in-lupus-patients/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology